Skip to main content
. 2012 Dec 12;7(12):e51470. doi: 10.1371/journal.pone.0051470

Figure 4. Disulfiram-sunitinib co-exposure reduces AR signalling in VCaP prostate cancer cells.

Figure 4

The expression of A) AR, B) PSA, C) ERG, D) MYC mRNA in response to disulfiram (DSF) and sunitinib (Su) exposures alone and in combination. E) AR and PSA protein expression in response to compound exposures alone and in combination. F) Quantification of AR protein expression in response to 6- and 24 h compound exposures. Asterisks indicate the statistical significance: *, P<0.05; **, P<0.01; and ***, P<0.005.